Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianjun Yu

Showing results (351-360 of 421) with videos related to

Pageof 43
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 12, 2025
ACSS2/AATF Drives Soluble FasL-Mediated CD8<sup>+</sup> T Cell Apoptosis in Pancreatic Neuroendocrine TumorsQin Dang, Ting Wang, Yan Wang, et al.
Molecular Cancer|April 5, 2024
Cancer immunometabolism: advent, challenges, and perspectiveQin Dang, Borui Li, Bing Jin, et al.
Cancer Medicine|January 12, 2019
Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgeryShuo Li, Huaxiang Xu, Chuntao Wu, et al.
Human Cell|April 8, 2022
Establishment and characterization of the third non-functional human pancreatic neuroendocrine tumor cell lineXin Lou, Zeng Ye, Xiaowu Xu, et al.
Cell Death and Differentiation|June 3, 2017
RIP1 kinase activity-dependent roles in embryonic development of Fadd-deficient miceYongbo Liu, Cunxian Fan, Yifan Zhang, et al.
Annals of Surgical Oncology|October 31, 2022
Maximum Value on Arterial Phase Computed Tomography Predicts Prognosis and Treatment Efficacy of Sunitinib for Pancreatic Neuroendocrine TumoursHaidi Chen, Zheng Li, Yuheng Hu, et al.
BMC Cancer|December 24, 2017
Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II studyRuihua Xu, Xianjun Yu, Jihui Hao, et al.
Gut|November 5, 2024
TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethalityMingming Xiao, Rong Tang, Haoqi Pan, et al.
Journal for Immunotherapy of Cancer|June 26, 2023
Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significanceXuan Zou, Xuan Lin, He Cheng, et al.
Cell Death & Disease|December 13, 2025
Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumorsXin Lou, Yihua Shi, Yi Qin, et al.
Pageof 43

Showing results (351-360 of 421) with videos related to

Sort By:
Pageof 43
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 12, 2025
ACSS2/AATF Drives Soluble FasL-Mediated CD8<sup>+</sup> T Cell Apoptosis in Pancreatic Neuroendocrine TumorsQin Dang, Ting Wang, Yan Wang, et al.
Molecular Cancer|April 5, 2024
Cancer immunometabolism: advent, challenges, and perspectiveQin Dang, Borui Li, Bing Jin, et al.
Cancer Medicine|January 12, 2019
Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgeryShuo Li, Huaxiang Xu, Chuntao Wu, et al.
Human Cell|April 8, 2022
Establishment and characterization of the third non-functional human pancreatic neuroendocrine tumor cell lineXin Lou, Zeng Ye, Xiaowu Xu, et al.
Cell Death and Differentiation|June 3, 2017
RIP1 kinase activity-dependent roles in embryonic development of Fadd-deficient miceYongbo Liu, Cunxian Fan, Yifan Zhang, et al.
Annals of Surgical Oncology|October 31, 2022
Maximum Value on Arterial Phase Computed Tomography Predicts Prognosis and Treatment Efficacy of Sunitinib for Pancreatic Neuroendocrine TumoursHaidi Chen, Zheng Li, Yuheng Hu, et al.
BMC Cancer|December 24, 2017
Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II studyRuihua Xu, Xianjun Yu, Jihui Hao, et al.
Gut|November 5, 2024
TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethalityMingming Xiao, Rong Tang, Haoqi Pan, et al.
Journal for Immunotherapy of Cancer|June 26, 2023
Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significanceXuan Zou, Xuan Lin, He Cheng, et al.
Cell Death & Disease|December 13, 2025
Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumorsXin Lou, Yihua Shi, Yi Qin, et al.
Pageof 43